04 Dec 2019 --- The EU Commission (EC) has granted Novel Food status to Danish biotechnology company Glycom for its 2’-Fucosyllactose/Difucosyllactose mixture (2’-FL/DFL). Having received the European Food Safety Authority’s (EFSA) recommendation, the EC concluded that the 2’-FL/DFL blend is safe for consumption in certain applications. With this greenlight, Glycom can now use this Human Milk Oligosaccharide (HMO) in a variety of uses on the EU market, including as a dietary supplement and in infant formula.
